(August 23, 2023, 12:25 PM EDT) -- WASHINGTON, D.C. — A patented treatment for myelofibrosis with the potential to treat other health conditions, including alopecia areata, was correctly declared obvious by the Patent Trial and Appeal Board, the Federal Circuit U.S. Court of Appeals said Aug. 22....